nTZDpa is a small molecule research compound that functions as a PPARγ partial agonist and exhibits antimicrobial properties. It is effective against both growing and persistent Staphylococcus aureus by disrupting the bacterial lipid bilayer, making it a candidate for studies targeting antibiotic-resistant infections in vitro.